Cargando…
Peptidylprolyl Isomerases as In Vivo Carriers for Drugs That Target Various Intracellular Entities
Analyses of sequences and structures of the cyclosporine A (CsA)-binding proteins (cyclophilins) and the immunosuppressive macrolide FK506-binding proteins (FKBPs) have revealed that they exhibit peculiar spatial distributions of charges, their overall hydrophobicity indexes vary within a considerab...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745455/ https://www.ncbi.nlm.nih.gov/pubmed/28961224 http://dx.doi.org/10.3390/biom7040072 |
_version_ | 1783288906308911104 |
---|---|
author | Galat, Andrzej |
author_facet | Galat, Andrzej |
author_sort | Galat, Andrzej |
collection | PubMed |
description | Analyses of sequences and structures of the cyclosporine A (CsA)-binding proteins (cyclophilins) and the immunosuppressive macrolide FK506-binding proteins (FKBPs) have revealed that they exhibit peculiar spatial distributions of charges, their overall hydrophobicity indexes vary within a considerable level whereas their points isoelectric (pIs) are contained from 4 to 11. These two families of peptidylprolyl cis/trans isomerases (PPIases) have several distinct functional attributes such as: (1) high affinity binding to some pharmacologically-useful hydrophobic macrocyclic drugs; (2) diversified binding epitopes to proteins that may induce transient manifolds with altered flexibility and functional fitness; and (3) electrostatic interactions between positively charged segments of PPIases and negatively charged intracellular entities that support their spatial integration. These three attributes enhance binding of PPIase/pharmacophore complexes to diverse intracellular entities, some of which perturb signalization pathways causing immunosuppression and other system-altering phenomena in humans. |
format | Online Article Text |
id | pubmed-5745455 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-57454552018-01-02 Peptidylprolyl Isomerases as In Vivo Carriers for Drugs That Target Various Intracellular Entities Galat, Andrzej Biomolecules Review Analyses of sequences and structures of the cyclosporine A (CsA)-binding proteins (cyclophilins) and the immunosuppressive macrolide FK506-binding proteins (FKBPs) have revealed that they exhibit peculiar spatial distributions of charges, their overall hydrophobicity indexes vary within a considerable level whereas their points isoelectric (pIs) are contained from 4 to 11. These two families of peptidylprolyl cis/trans isomerases (PPIases) have several distinct functional attributes such as: (1) high affinity binding to some pharmacologically-useful hydrophobic macrocyclic drugs; (2) diversified binding epitopes to proteins that may induce transient manifolds with altered flexibility and functional fitness; and (3) electrostatic interactions between positively charged segments of PPIases and negatively charged intracellular entities that support their spatial integration. These three attributes enhance binding of PPIase/pharmacophore complexes to diverse intracellular entities, some of which perturb signalization pathways causing immunosuppression and other system-altering phenomena in humans. MDPI 2017-09-29 /pmc/articles/PMC5745455/ /pubmed/28961224 http://dx.doi.org/10.3390/biom7040072 Text en © 2017 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Galat, Andrzej Peptidylprolyl Isomerases as In Vivo Carriers for Drugs That Target Various Intracellular Entities |
title | Peptidylprolyl Isomerases as In Vivo Carriers for Drugs That Target Various Intracellular Entities |
title_full | Peptidylprolyl Isomerases as In Vivo Carriers for Drugs That Target Various Intracellular Entities |
title_fullStr | Peptidylprolyl Isomerases as In Vivo Carriers for Drugs That Target Various Intracellular Entities |
title_full_unstemmed | Peptidylprolyl Isomerases as In Vivo Carriers for Drugs That Target Various Intracellular Entities |
title_short | Peptidylprolyl Isomerases as In Vivo Carriers for Drugs That Target Various Intracellular Entities |
title_sort | peptidylprolyl isomerases as in vivo carriers for drugs that target various intracellular entities |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745455/ https://www.ncbi.nlm.nih.gov/pubmed/28961224 http://dx.doi.org/10.3390/biom7040072 |
work_keys_str_mv | AT galatandrzej peptidylprolylisomerasesasinvivocarriersfordrugsthattargetvariousintracellularentities |